📰 Triple Class Exposed News

Triple Class Exposed News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Triple Class Exposed. Real-time updates on events, politics, business and more.

KarMMA-3: Trial of Ide-Cel in Patients with Triple Class Exposed R/R MM

January 24, 2024

Experts discuss the recent data presented at ASH 2023 from the KarMMA-3 trial in which ide-cel vs standard of care was studied in triple class exposed R/R MM patients.

Refractory Multiple Myeloma Triple Class Exposed Multiple Myeloma Relapsed Refractory Multiple Myeloma Relapsed Refractory Mm Mash 2023

Source: onclive.com

Regeneron to Highlight Scientific Advancements Across

November 3, 2023

Ten abstracts, including three oral presentations, spotlight the expanding body of evidence supporting odronextamab in follicular lymphoma and diffuse...

San Diego United States Audrey Le Floch Jone Arnason Pozelimab Monotherapy Leah Sabin

Source: globenewswire.com

Regeneron to Highlight Scientific Advancements Across Diversified Pipeline in Difficult-to-Treat Blood Cancers and Disorders at ASH

November 3, 2023

Ten abstracts, including three oral presentations, spotlight the expanding body of evidence supporting odronextamab in follicular lymphoma and diffuse large B-cell lymphoma Additional presentations...

San Diego United States Pozelimab Monotherapy Odronextamab Monotherapy Sabarish Ram Ayyappan Qiufei Ma

Source: marketscreener.com

Bristol Myers Squibb's First Disclosures and New Data at ASH 2023 Highlight Company's Leadership and Progress in Cell Therapy, Targeted Protein Degradation and Novel Approaches in Hematology -November 02, 2023 at 11:35 am EDT

November 2, 2023

First presentation of results from primary analysis of Phase 2 TRANSCEND FL study evaluating second-line treatment with Breyanzi® in relapsed or refractory follicular lymphoma demonstrate its...

United States San Diego Sikander Ailawadhi Francesco Passamonti Lisocabtagene Maraleucel Guillaume Cartron